发明名称 |
TREATMENT OF NUCLEAR FACTOR (ERYTHROID-DERIVED 2)-LIKE 2 (NRF2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO NRF2 |
摘要 |
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Nuclear factor (erythroid-derived 2)-like 2 (NRF2), in particular, by targeting natural antisense polynucleotides of Nuclear factor (erythroid-derived 2)-like 2 (NRF2). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of NRF2. |
申请公布号 |
WO2010107733(A2) |
申请公布日期 |
2010.09.23 |
申请号 |
WO2010US27394 |
申请日期 |
2010.03.16 |
申请人 |
CURNA, INC.;COLLARD, JOSEPH;KHORKOVA SHERMAN, OLGA;COITO, CARLOS |
发明人 |
COLLARD, JOSEPH;KHORKOVA SHERMAN, OLGA;COITO, CARLOS |
分类号 |
C12N15/63;A61K48/00;C07H21/00;C12N15/113;C12Q1/68 |
主分类号 |
C12N15/63 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|